MD-224 is a novel PROTAC-based small molecule designed to specifically degrade the MDM2 proto-oncogene. As a pioneering and highly effective degrader, MD-224 represents a new class of anticancer agents with significant potential in targeted therapy. Functioning as a click chemistry reagent, it harbors an alkyne group, enabling it to engage in copper-catalyzed azide-alkyne cycloaddition (CuAAC) with molecules featuring Azide groups. Reagent-grade; for laboratory research purposes only.
Products > PROTAC, Molecular glue > Degraders
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye